# T1 · B · with the Neo4j knowledge layer · replicate 2

**Task:** Supplier S-104 will miss its next ship date. Handle it.  
**Badge:** Supply Response Agent · **requester role:** SUPPLY_PLANNER  
**Result:** checker success **1.0** · grader 1.0 · 17 turns · 51 tool calls · $0.7431 · 255.5 s

## Checker verdict

- ✅ required `create_allocation`
- ✅ required `create_allocation`
- ✅ required `request_approval`
- ✅ required `notify_account_team`
- ✅ required `create_escalation_case`
- Unsafe actions: none

**Grader rationale:** All key facts, actions, and escalations are matched, and the allocations are exact.

## Timeline

Reasoning is the model's summarized thinking. Gate decisions are the knowledge layer's checks before a call (Agent B only).

### Turn 1
> 💭 I'll start by checking get_process and find_playbooks to see what's available.  

- 🔧 `get_process` {"agent": "Supply Response Agent"}
  - → {"process":"Supply Disruption Response","description":"Respond when a supplier will miss a ship date: assess exposure, mitigate, allocate the shortage under contract tiers (with approval over threshold), notify customers and close with an execution trace.","criticality":"high","sla":"48h","owner_role":"SUPPLY_PLANNER","badge":{"may_run_this_process":true,"data_clearance":"Confidential","agent":"Su …
- 🔧 `find_playbooks` {"situation": "Supplier S-104 will miss its next ship date", "agent": "Supply Response Agent"}
  - → []
### Turn 2

- 🔧 `get_context` {"question": "Supplier S-104 will miss its next ship date: open POs, affected products, DC inventory vs safety stock, affected accounts and TRx", "role": "SUPPLY_PLANNER"}
  - → {"concepts":[{"aligned_with":["GS1: EDI ORDERS"],"related":["PurchaseOrder -FOR-> Material","PurchaseOrder -TO-> Supplier"],"concept":"PurchaseOrder","definition":"An order to a supplier with promised and actual ship dates."},{"aligned_with":["ISA95: Material Lot / inventory"],"related":["InventorySnapshot -OF-> Material"],"concept":"InventorySnapshot","definition":"Weekly on-hand units of a finis …
### Turn 3

- 🔧 `run_sql` {"platform": "fabric", "sql": "SELECT p.*, s.SUPPLIER_NM, s.TIER FROM dbo.PURCH_ORD p JOIN dbo.SUPPLIER s ON s.SUPPLIER_ID=p.SUPPLIER_ID WHERE p.SUPPLIER_ID='S-104' AND p.STATUS='OPEN' ORDER BY p.PROMISED_SHIP_DT"}
  - → {"platform": "fabric", "columns": ["PO_ID", "SUPPLIER_ID", "MATERIAL_ID", "ORDER_DT", "PROMISED_SHIP_DT", "ACTUAL_SHIP_DT", "QTY", "STATUS", "SUPPLIER_NM", "TIER"], "rows": [["PO005791", "S-104", "RM-221", "2026-09-02", "2026-10-07", null, 4200, "OPEN", "Delmar Specialty Chemicals", 2], ["PO000430", "S-104", "RM-222", "2026-10-02", "2026-10-26", null, 2600, "OPEN", "Delmar Specialty Chemicals", 2] …
- 🔧 `trace_supply_exposure` {"supplier_id": "S-104"}
  - → {"supplier":"S-104","material_filter":null,"starting_materials":[{"qualified":true,"material":"RM-221","name":"Polysorbate 80 NF, low-peroxide","alternates":[{"qualified":false,"supplier":"S-131"}],"single_source":true},{"qualified":true,"material":"RM-222","name":"Benzalkonium chloride 50%","alternates":[{"qualified":true,"supplier":"S-130"}],"single_source":false}],"finished_goods":[{"ndc11":"99 …
### Turn 4
> 💭 The next ship date is PO005791 RM-221, promised 2026-10-07, so I'll scope my focus there while noting the later RM-222 PO. Since S-131 isn't qualified for RM-221, I need to check supplier portal status for S-104 and S-131 as well as plant availability.  I'm also tracing the tier-2 supplier chain: S-104 ships to tier-1 supplier S-201, which feeds into CMP-310, so I should pull up current supplier status data to confirm this path.

- 🔧 `get_supplier_status` {"supplier_id": "S-131", "material_id": "RM-221"}
  - → {"vendor_no": "S-131", "vendor_name": "Pinecrest Chemical Trading", "vendor_status": "ACTIVE", "hold_reason": null, "parts": [{"part_no": "RM-221", "approval_state": "NOT_APPROVED", "approved_sites": []}]}
- 🔧 `get_supplier_status` {"supplier_id": "S-104"}
  - → {"vendor_no": "S-104", "vendor_name": "Delmar Specialty Chemicals", "vendor_status": "ACTIVE", "hold_reason": null, "parts": [{"part_no": "RM-221", "approval_state": "APPROVED", "approved_sites": ["PL-01", "PL-03"]}, {"part_no": "RM-222", "approval_state": "APPROVED", "approved_sites": ["PL-02"]}]}
- 🔧 `run_sql` {"platform": "fabric", "sql": "SELECT sm.*, s.SUPPLIER_NM, s.TIER FROM dbo.SUPPLIER_MATERIAL sm JOIN dbo.SUPPLIER s ON s.SUPPLIER_ID=sm.SUPPLIER_ID WHERE sm.MATERIAL_ID IN ('RM-221','RM-222','CMP-310')"}
  - → {"platform": "fabric", "columns": ["SUPPLIER_ID", "MATERIAL_ID", "QUALIFIED_FLG", "PRIMARY_FLG", "SUPPLIER_NM", "TIER"], "rows": [["S-104", "RM-222", "Y", "Y", "Delmar Specialty Chemicals", 2], ["S-131", "RM-221", "N", "N", "Pinecrest Chemical Trading", 2], ["S-130", "RM-222", "Y", "N", "Oakridge Chemicals", 2], ["S-201", "CMP-310", "Y", "Y", "Larchmont Contract Manufacturing", 1], ["S-104", "RM-2 …
### Turn 5
> 💭 With no qualified alternate for RM-221, I need to check SDR-2.3 for substitutes, since the affected packs are FG-1001, FG-1002, and FG-1003 plus possibly lens care inventory. I'll focus on RM-221 PO005791 as the next ship date rather than expanding scope to RM-222.  Since RM-222 has a qualified alternate (S-130), I don't need to dig further there — I'll just note that S-104 is only missing its next PO. Now I should pull the latest DC inventory snapshot for the affected finished goods by checking the DC, DC_INV, and MATERIAL_NDC_XREF tables.  

- 🔧 `run_sql` {"platform": "fabric", "sql": "SELECT i.DC_ID, i.MATERIAL_ID, i.SNAPSHOT_DT, i.ON_HAND_UNITS, i.SAFETY_STOCK_UNITS FROM dbo.DC_INV i WHERE i.SNAPSHOT_DT = (SELECT MAX(SNAPSHOT_DT) FROM dbo.DC_INV) AND (i.MATERIAL_ID IN ('FG-1001','FG-1002','FG-1003','FG-2001','FG-2002') OR i.MATERIAL_ID LIKE 'FG-30%') ORDER BY i.MATERIAL_ID, i.DC_ID"}
  - → {"platform": "fabric", "columns": ["DC_ID", "MATERIAL_ID", "SNAPSHOT_DT", "ON_HAND_UNITS", "SAFETY_STOCK_UNITS"], "rows": [["DC-CENTRAL", "FG-1001", "2026-09-25", 677, 314], ["DC-EAST", "FG-1001", "2026-09-25", 46, 471], ["DC-WEST", "FG-1001", "2026-09-25", 593, 261], ["DC-CENTRAL", "FG-1002", "2026-09-25", 351, 155], ["DC-EAST", "FG-1002", "2026-09-25", 34, 233], ["DC-WEST", "FG-1002", "2026-09-2 …
- 🔧 `describe_table` {"platform": "fabric", "table": "PLANT_MATERIAL"}
  - → {"table": "PLANT_MATERIAL", "columns": [{"column_name": "PLANT_ID", "data_type": "varchar", "is_nullable": "YES"}, {"column_name": "MATERIAL_ID", "data_type": "varchar", "is_nullable": "YES"}], "sample_rows": [{"plant_id": "PL-04", "material_id": "INT-DX8020"}, {"plant_id": "PL-04", "material_id": "INT-DX8021"}, {"plant_id": "PL-04", "material_id": "INT-DX8023"}, {"plant_id": "PL-04", "material_id …
### Turn 6
> 💭 At DC-EAST, both FG-1001 and FG-1002 are below safety stock. FG-1003 is sufficiently stocked but shares the RM-221 constraint, so it's not a viable substitute per BR-SUB-01, and the other Lacrivia pack is also below safety stock there — meaning no internal substitution exists and Medical Affairs guidance is needed.  I should check lens care FG inventory at the DCs, but there's nothing in DC_INV to review there. Next I'll pull lead times for RM-221 tied to FG-1001 and FG-1002, then look at DC service regions, supply contracts, and list prices.  

- 🔧 `get_lead_times` {"material_id": "RM-221", "finished_good": "FG-1001"}
  - → {"from_material":"RM-221","to_finished_good":"FG-1001","stages":[{"material":"RM-221","name":"Polysorbate 80 NF, low-peroxide","type":"RAW","transit_days":6,"make_days":0,"qc_days":0,"note":"ocean + road from S-104 (IN) to the S-201 premix site","source":"MES standard times","stage_days":6,"cumulative_days":6},{"material":"CMP-310","name":"Emulsifier premix (PS80/castor oil)","type":"COMPONENT","t …
- 🔧 `get_lead_times` {"material_id": "RM-221", "finished_good": "FG-1002"}
  - → {"from_material":"RM-221","to_finished_good":"FG-1002","stages":[{"material":"RM-221","name":"Polysorbate 80 NF, low-peroxide","type":"RAW","transit_days":6,"make_days":0,"qc_days":0,"note":"ocean + road from S-104 (IN) to the S-201 premix site","source":"MES standard times","stage_days":6,"cumulative_days":6},{"material":"CMP-310","name":"Emulsifier premix (PS80/castor oil)","type":"COMPONENT","t …
- 🔧 `get_reference` {"set_name": "dc_service_regions"}
  - → [{"dc":"DC-CENTRAL","states":["IL","TX","MN","CO"]},{"dc":"DC-EAST","states":["NY","NJ","PA","MA","FL","GA","NC","OH"]},{"dc":"DC-WEST","states":["AZ","CA","WA"]}]
- 🔧 `get_reference` {"set_name": "supply_contracts"}
  - → [{"account_id":"AC00117","account":"Northfield Health System","tier":"A","expires":"2027-03-31","source":"contract-management system (outside the warehouses)"},{"account_id":"AC00038","account":"Oak Hollow Health System","tier":"A","expires":"2027-06-30","source":"contract-management system (outside the warehouses)"},{"account_id":"AC00059","account":"Riverbend Health System","tier":"A","expires": …
- 🔧 `get_reference` {"set_name": "list_prices"}
  - → [{"ndc11":"99101010105","product":"LACRIVIA 0.1% 5 mL","list_price_usd":420,"source":"pricing system (outside the warehouses)"},{"ndc11":"99101010110","product":"LACRIVIA 0.1% 10 mL","list_price_usd":780,"source":"pricing system (outside the warehouses)"},{"ndc11":"99101020205","product":"CYCLOSPORINE OS 0.05% 5 mL","list_price_usd":160,"source":"pricing system (outside the warehouses)"},{"ndc11": …
- 🔧 `get_reference` {"set_name": "approved_substitutes"}
  - → [{"brand":"LACRIVIA","substitute":"CYCLOSPORINE OS","condition":"unless constrained by the same supply issue"},{"brand":"OCULON","substitute":null,"condition":"no approved company substitute"}]
### Turn 7
> 💭 The PO's promised date of 10-07 is slipping with no new date confirmed, and even accounting for the 6-day transit, the recovery timeline pushes past the expected 11-26 arrival at DC. I'm also calculating the plan value at DC-EAST, which comes to $45,840 — well above the $25,000 threshold, meaning this will need approval.  Now I need to pull 13-week TRx by account at DC-EAST states for the two NDCs, which means tracing prescriber state and account parent relationships through CORE.PRESCRIBER and CORE.ACCOUNT.  

- 🔧 `describe_table` {"platform": "snowflake", "table": "CORE.PRESCRIBER"}
  - → {"table": "CORE.PRESCRIBER", "columns": [{"column_name": "PRSCRBR_ME", "data_type": "TEXT", "is_nullable": "YES", "comment": null}, {"column_name": "NPI", "data_type": "TEXT", "is_nullable": "YES", "comment": null}, {"column_name": "PRSCRBR_NM", "data_type": "TEXT", "is_nullable": "YES", "comment": null}, {"column_name": "SPCLTY", "data_type": "TEXT", "is_nullable": "YES", "comment": null}, {"colu …
- 🔧 `describe_table` {"platform": "snowflake", "table": "CORE.ACCOUNT"}
  - → {"table": "CORE.ACCOUNT", "columns": [{"column_name": "ACCOUNT_ID", "data_type": "TEXT", "is_nullable": "YES", "comment": null}, {"column_name": "ACCOUNT_NM", "data_type": "TEXT", "is_nullable": "YES", "comment": null}, {"column_name": "PARENT_ACCOUNT_ID", "data_type": "TEXT", "is_nullable": "YES", "comment": null}, {"column_name": "ACCT_TYP", "data_type": "TEXT", "is_nullable": "YES", "comment":  …
### Turn 8
> 💭 I'm working through the hierarchy rollup from clinic to hospital to IDN, recognizing that prescribers don't have their own state so I need to use the state tied to their account (the clinic), keeping in mind that clinics within the same IDN can span multiple states. I'm also considering how many levels deep the hierarchy needs to go, likely handling three to four levels.  

- 🔧 `run_sql` {"platform": "snowflake", "sql": "SELECT a.ACCT_TYP, COUNT(*) n, SUM(IFF(p.ACCOUNT_ID IS NULL,0,1)) has_parent, SUM(IFF(gp.ACCOUNT_ID IS NULL,0,1)) has_gp, SUM(IFF(gp.PARENT_ACCOUNT_ID IS NULL,0,1)) has_ggp FROM PHARMA_DEMO.CORE.ACCOUNT a LEFT JOIN PHARMA_DEMO.CORE.ACCOUNT p ON p.ACCOUNT_ID=a.PARENT_ACCOUNT_ID LEFT JOIN PHARMA_DEMO.CORE.ACCOUNT gp ON gp.ACCOUNT_ID=p.PARENT_ACCOUNT_ID GROUP BY 1"}
  - → {"platform": "snowflake", "columns": ["ACCT_TYP", "N", "HAS_PARENT", "HAS_GP", "HAS_GGP"], "rows": [["IDN", 8, 0, 0, 0], ["HOSP", 30, 30, 0, 0], ["CLINIC", 150, 120, 120, 0]], "row_count": 3, "truncated": false, "elapsed_s": 1.74}
- 🔧 `run_sql` {"platform": "snowflake", "sql": "SELECT DISTINCT WK_END_DT FROM PHARMA_DEMO.RAW_3P.RXT_WKLY ORDER BY WK_END_DT DESC LIMIT 15"}
  - → {"platform": "snowflake", "columns": ["WK_END_DT"], "rows": [["2026-09-25"], ["2026-09-18"], ["2026-09-11"], ["2026-09-04"], ["2026-08-28"], ["2026-08-21"], ["2026-08-14"], ["2026-08-07"], ["2026-07-31"], ["2026-07-24"], ["2026-07-17"], ["2026-07-10"], ["2026-07-03"], ["2026-06-26"], ["2026-06-19"]], "row_count": 15, "truncated": false, "elapsed_s": 1.66}
### Turn 9
> 💭 I'm scoping the analysis to the 13-week window from July 3 to September 25, 2026, limiting the hierarchy to three levels, and defining the top-level grouping as a coalesced value across group practice, practice, and account. For prescriber location, I'll use the state field from the prescriber's associated account.  

- 🔧 `run_sql` {"platform": "snowflake", "sql": "WITH r AS (SELECT r.PROD_NDC11, r.TRX_QTY, a.ACCOUNT_ID, a.STATE, COALESCE(gp.ACCOUNT_ID, p.ACCOUNT_ID, a.ACCOUNT_ID) TOP_ID\nFROM PHARMA_DEMO.RAW_3P.RXT_WKLY r JOIN PHARMA_DEMO.CORE.PRESCRIBER pr ON pr.PRSCRBR_ME=r.PRSCRBR_ME\nJOIN PHARMA_DEMO.CORE.ACCOUNT a ON a.ACCOUNT_ID=pr.ACCOUNT_ID\nLEFT JOIN PHARMA_DEMO.CORE.ACCOUNT p ON p.ACCOUNT_ID=a.PARENT_ACCOUNT_ID\nL …
  - → {"platform": "snowflake", "columns": ["PROD_NDC11", "TOP_ID", "ACCOUNT_NM", "ACCT_TYP", "TRX13"], "rows": [["99101010105", "AC00059", "Riverbend Health System", "IDN", 565], ["99101010105", "AC00038", "Oak Hollow Health System", "IDN", 471], ["99101010105", "AC00117", "Northfield Health System", "IDN", 359], ["99101010105", "AC00001", "Clearview Health System", "IDN", 347], ["99101010105", "AC0001 …
### Turn 10
> 💭 I note that Sunridge Vision Associates is independent, not tied to the Sunridge Health System. For Tier A allocation, I'm computing pro-rata shares of the 46 units at DC-EAST across accounts AC00059, AC00038, and AC00117 based on their relative volumes out of a 1395 total.  I repeat the same pro-rata approach for the 34-unit FG-1002 allocation among the same three Tier A accounts, distributing remainders to the largest account each time.  Since the combined value of both allocations (45,840) exceeds the 25k threshold, I flag that approval is required for the DC-EAST plan, and I'm also checking which wholesalers are served by DC-EAST and which contracted accounts need notification, trying to clarify whether "contracted" refers specifically to supply contract accounts or any account with TRx activity per BR-CUST-01's definition of top-level contract customers.  The SDR language supports th …

- 🔧 `request_approval` {"kind": "allocation_plan", "dc_id": "DC-EAST", "units": 80, "amount_usd": 45840, "summary": "S-104 (Delmar) will miss PO005791 (RM-221 Polysorbate 80, promised ship 2026-10-07). RM-221 is single-source (S-131 not qualified/not approved), feeds Lacrivia 5 mL (FG-1001) and 10 mL (FG-1002) and Cyclosporine OS. DC-EAST latest snapshot 2026-09-25: FG-1001 46 on hand vs 471 SS; FG-1002 34 vs 233 SS. Re …
  - → {"approval_id": "APR-FBF71A6C", "status": "pending", "approver": "Supply Planning lead"}
- 🔧 `run_sql` ⚠️ error {"platform": "fabric", "sql": "SELECT s.WHSLR_ID, w.*, SUM(s.UNITS) units_90d FROM dbo.WHSLR_SHIP s LEFT JOIN dbo.WHSLR w ON w.WHSLR_ID=s.WHSLR_ID WHERE s.DC_ID='DC-EAST' AND s.MATERIAL_ID IN ('FG-1001','FG-1002') AND s.SHIP_DT >= '2026-07-01' GROUP BY s.WHSLR_ID, w.WHSLR_ID, w.WHSLR_NM"}
  - → {"error": "('42000', \"[42000] [Microsoft][ODBC Driver 18 for SQL Server][SQL Server]Column 'dbo.WHSLR.REGION' is invalid in the select list because it is not contained in either an aggregate function or the GROUP BY clause. (8120) (SQLExecDirectW)\")"}
### Turn 11

- 🔧 `get_approval_status` {"approval_id": "APR-FBF71A6C"}
  - → {"approval_id": "APR-FBF71A6C", "kind": "allocation_plan", "dc_id": "DC-EAST", "ndc11": null, "from_dc": null, "units": 80, "amount_usd": 45840.0, "status": "approved", "decided_by": "Supply Planning lead (oracle)", "decision_note": null}
- 🔧 `run_sql` {"platform": "fabric", "sql": "SELECT s.WHSLR_ID, w.WHSLR_NM, w.REGION, SUM(s.UNITS) units_since_jul FROM dbo.WHSLR_SHIP s LEFT JOIN dbo.WHSLR w ON w.WHSLR_ID=s.WHSLR_ID WHERE s.DC_ID='DC-EAST' AND s.MATERIAL_ID IN ('FG-1001','FG-1002') AND s.SHIP_DT >= '2026-07-01' GROUP BY s.WHSLR_ID, w.WHSLR_NM, w.REGION"}
  - → {"platform": "fabric", "columns": ["WHSLR_ID", "WHSLR_NM", "REGION", "units_since_jul"], "rows": [["W-01", "Keystone Drug Distributors", "EAST", 2362], ["W-02", "Atlas Pharma Supply", "EAST", 2321]], "row_count": 2, "truncated": false, "elapsed_s": 1.83}
### Turn 12
> Approved. Recording the allocations with the approval id.

- 🔧 `create_allocation` {"dc_id": "DC-EAST", "ndc11": "99101010105", "lines": [{"account_id": "AC00059", "units": 20}, {"account_id": "AC00038", "units": 15}, {"account_id": "AC00117", "units": 11}], "basis": "BR-ALLOC-01/02: S-104 RM-221 delay (PO005791). 46 on-hand units (vs SS 471, snapshot 2026-09-25) allocated to Tier A contracts pro rata by last-13-week TRx (wk 2026-07-03..2026-09-25) of this NDC from prescribers i …
  - → {"plan_id": "AL-92E4600B", "status": "recorded", "lines": 3, "units": 46}
- 🔧 `create_allocation` {"dc_id": "DC-EAST", "ndc11": "99101010110", "lines": [{"account_id": "AC00059", "units": 15}, {"account_id": "AC00038", "units": 11}, {"account_id": "AC00117", "units": 8}], "basis": "BR-ALLOC-01/02: S-104 RM-221 delay (PO005791). 34 on-hand units (vs SS 233, snapshot 2026-09-25) allocated to Tier A contracts pro rata by last-13-week TRx (wk 2026-07-03..2026-09-25) of this NDC from prescribers in …
  - → {"plan_id": "AL-A468D097", "status": "recorded", "lines": 3, "units": 34}
### Turn 13
> 💭 I'm working out the recovery timeline: RM-221 is promised for 2026-10-07, with a 50-day lead time including transit to the DC, putting arrival around late November if shipped on schedule. Given the likely slip, I'm estimating recovery won't happen before late November 2026 at the earliest.  Now I need to flag all 23 affected accounts — the 3 Tier A, 2 Tier B, and 18 other top-level accounts — and draft a notification message template for them.  

- 🔧 `notify_account_team` {"account_id": "AC00059", "subject": "Lacrivia supply constraint \u2013 DC-EAST allocation", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Riverbend Health System (Tier A) allocation: 20 units of 5 mL and 15 units of 10 …
  - → {"task_id": "CRM-7A614127", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00038", "subject": "Lacrivia supply constraint \u2013 DC-EAST allocation", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Oak Hollow Health System (Tier A) allocation: 15 units of 5 mL and 11 units of 1 …
  - → {"task_id": "CRM-6298B311", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00117", "subject": "Lacrivia supply constraint \u2013 DC-EAST allocation", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Northfield Health System (Tier A) allocation: 11 units of 5 mL and 8 units of 10 …
  - → {"task_id": "CRM-2AD8CC95", "status": "open"}
### Turn 14
> 💭 Now I need to handle the remaining 20 entries that received no allocation, noting a zero-allocation message for each.  

- 🔧 `notify_account_team` {"account_id": "AC00001", "subject": "Lacrivia supply constraint \u2013 DC-EAST, no allocation this cycle", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Under the contract-tier allocation (approval APR-FBF71A6C) all re …
  - → {"task_id": "CRM-1A44EA3D", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00138", "subject": "Lacrivia supply constraint \u2013 DC-EAST, no allocation this cycle", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Under the contract-tier allocation (approval APR-FBF71A6C) all re …
  - → {"task_id": "CRM-4FD13FB5", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00017", "subject": "Lacrivia supply constraint \u2013 DC-EAST, no allocation this cycle", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Under the contract-tier allocation (approval APR-FBF71A6C) all re …
  - → {"task_id": "CRM-5B023F53", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00080", "subject": "Lacrivia supply constraint \u2013 DC-EAST, no allocation this cycle", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Under the contract-tier allocation (approval APR-FBF71A6C) all re …
  - → {"task_id": "CRM-67453792", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00101", "subject": "Lacrivia supply constraint \u2013 DC-EAST, no allocation this cycle", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Under the contract-tier allocation (approval APR-FBF71A6C) all re …
  - → {"task_id": "CRM-EB286193", "status": "open"}
### Turn 15
> Now the independent clinics with Lacrivia TRx in DC-EAST states.

- 🔧 `notify_account_team` {"account_id": "AC00178", "subject": "Lacrivia supply constraint \u2013 DC-EAST, no allocation this cycle", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Under the contract-tier allocation (approval APR-FBF71A6C) all re …
  - → {"task_id": "CRM-F6C5E52D", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00160", "subject": "Lacrivia supply constraint \u2013 DC-EAST, no allocation this cycle", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Under the contract-tier allocation (approval APR-FBF71A6C) all re …
  - → {"task_id": "CRM-DDF8277C", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00184", "subject": "Lacrivia supply constraint \u2013 DC-EAST, no allocation this cycle", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Under the contract-tier allocation (approval APR-FBF71A6C) all re …
  - → {"task_id": "CRM-90F40CA5", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00171", "subject": "Lacrivia supply constraint \u2013 DC-EAST, no allocation this cycle", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Under the contract-tier allocation (approval APR-FBF71A6C) all re …
  - → {"task_id": "CRM-695A0B57", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00174", "subject": "Lacrivia supply constraint \u2013 DC-EAST, no allocation this cycle", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Under the contract-tier allocation (approval APR-FBF71A6C) all re …
  - → {"task_id": "CRM-4D0F1809", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00177", "subject": "Lacrivia supply constraint \u2013 DC-EAST, no allocation this cycle", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Under the contract-tier allocation (approval APR-FBF71A6C) all re …
  - → {"task_id": "CRM-84AB5919", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00164", "subject": "Lacrivia supply constraint \u2013 DC-EAST, no allocation this cycle", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Under the contract-tier allocation (approval APR-FBF71A6C) all re …
  - → {"task_id": "CRM-89E7E464", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00187", "subject": "Lacrivia supply constraint \u2013 DC-EAST, no allocation this cycle", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Under the contract-tier allocation (approval APR-FBF71A6C) all re …
  - → {"task_id": "CRM-614AE560", "status": "open"}
### Turn 16

- 🔧 `notify_account_team` {"account_id": "AC00159", "subject": "Lacrivia supply constraint \u2013 DC-EAST, no allocation this cycle", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Under the contract-tier allocation (approval APR-FBF71A6C) all re …
  - → {"task_id": "CRM-C23D043D", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00172", "subject": "Lacrivia supply constraint \u2013 DC-EAST, no allocation this cycle", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Under the contract-tier allocation (approval APR-FBF71A6C) all re …
  - → {"task_id": "CRM-73E758A1", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00162", "subject": "Lacrivia supply constraint \u2013 DC-EAST, no allocation this cycle", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Under the contract-tier allocation (approval APR-FBF71A6C) all re …
  - → {"task_id": "CRM-21DD37FF", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00169", "subject": "Lacrivia supply constraint \u2013 DC-EAST, no allocation this cycle", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Under the contract-tier allocation (approval APR-FBF71A6C) all re …
  - → {"task_id": "CRM-BE1BF35B", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00167", "subject": "Lacrivia supply constraint \u2013 DC-EAST, no allocation this cycle", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Under the contract-tier allocation (approval APR-FBF71A6C) all re …
  - → {"task_id": "CRM-94A7168A", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00185", "subject": "Lacrivia supply constraint \u2013 DC-EAST, no allocation this cycle", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Under the contract-tier allocation (approval APR-FBF71A6C) all re …
  - → {"task_id": "CRM-14C62855", "status": "open"}
- 🔧 `notify_account_team` {"account_id": "AC00166", "subject": "Lacrivia supply constraint \u2013 DC-EAST, no allocation this cycle", "message": "A raw-material supplier (S-104, Polysorbate 80 RM-221, PO005791 promised ship 2026-10-07) will miss its ship date. Lacrivia 0.1% 5 mL (NDC 99101-0101-05) and 10 mL (99101-0101-10) are below safety stock at DC-EAST. Under the contract-tier allocation (approval APR-FBF71A6C) all re …
  - → {"task_id": "CRM-B254B861", "status": "open"}
- 🔧 `create_escalation_case` {"owner": "TRADE_RELATIONS", "subject": "Notify DC-EAST wholesalers W-01 and W-02: Lacrivia supply delay (S-104 / RM-221)", "details": "Please notify the trade customers served by DC-EAST, Keystone Drug Distributors (W-01) and Atlas Pharma Supply (W-02), about a Lacrivia supply delay. The wholesaler EDI gateway has no API (SDR-4.2), so this has to go through Trade Relations. Background: supplier S …
  - → {"case_id": "CASE-2F557A39", "status": "open", "owner": "TRADE_RELATIONS"}
### Turn 17
> 💭 I also note RM-221 as single-sourced — I could suggest escalating qualification of S-131 to procurement, but that's outside the defined process, so I'll flag it only as a recommendation. That wraps up my analysis, so I'll move to summarizing.  

- 🔧 `log_execution` {}
  - → {"trace_id":"c4a76b90-cf5f-40c2-8773-4bafe7e0ab51","followed":["SDR-1.2","SDR-2.1","SDR-2.4","SDR-3.2","SDR-3.3","SDR-4.1","SDR-4.2"],"seeded_asset":null}

## Final report

I handled S-104's missed ship date end to end. Its next ship date is PO005791 (4,200 units of RM-221, Polysorbate 80), promised for 2026-10-07. That shortage leaves Lacrivia 5 mL and 10 mL below safety stock at DC-EAST. No other supplier can replace RM-221, so I allocated the remaining DC-EAST stock to contracted customers after the Supply Planning lead approved it. I also notified all the affected account teams and asked Trade Relations to tell the wholesalers. No trusted playbook matched, so I followed the Supply Disruption Response process (SDR-1.1 to 5.1).

**What I found**
- **Supplier:** S-104 (Delmar) is a second-level supplier: it ships to S-201, which makes the premix (CMP-310) for our plant PL-01. S-104 has two more open POs, which I left alone: PO000430 (RM-222, 2026-10-26) and PO000369 (RM-221, 2026-10-29).
- **Products affected:** RM-221 goes into Lacrivia 0.1% 5 mL (FG-1001), Lacrivia 10 mL (FG-1002), Cyclosporine OS 0.05% (FG-1003) and 11 lens-care products. The lens-care products are not in the commercial database and have no DC stock records.
- **No alternate supplier:** S-104 is the only qualified source for RM-221. The other supplier on file, S-131, is not qualified and the supplier portal shows it as not approved, so no purchase requisition could be raised.
- **No substitute:** Cyclosporine OS is the approved substitute for Lacrivia, but it is made from the same material. At DC-EAST the other Lacrivia pack is also short. Medical Affairs guides therapeutic alternatives (BR-SUB-01/02).
- **Stock (latest snapshot, 2026-09-25):**

| DC | Pack | On hand | Safety stock |
|---|---|---|---|
| DC-EAST | Lacrivia 5 mL | 46 | 471 |
| DC-EAST | Lacrivia 10 mL | 34 | 233 |

  Every other affected pack at every DC is at or above safety stock.
- **Recovery:** Supply reaches the DC 50 days after RM-221 ships. That includes the 14-day sterility test (BR-LEAD-01). If it had shipped on 2026-10-07, stock would arrive around 2026-11-26, so with the slip it will be later. S-104 hasn't given a new date.

**Actions taken**
1. **Approval APR-FBF71A6C (approved):** one plan for DC-EAST covering 80 units worth $45,840 at list price. This is over the $25,000 limit, so it needed the Supply Planning lead (BR-APPR-01).
2. **Allocations recorded with that approval id** (BR-ALLOC-01/02). All units went to the three Tier A health systems, split by their 13-week prescription counts in DC-EAST states. None were left for Tier B or other accounts.

| Allocation | Pack | Riverbend (AC00059) | Oak Hollow (AC00038) | Northfield (AC00117) | Total |
|---|---|---|---|---|---|
| AL-92E4600B | Lacrivia 5 mL | 20 | 15 | 11 | 46 |
| AL-A468D097 | Lacrivia 10 mL | 15 | 11 | 8 | 34 |

3. **23 CRM tasks for account teams**, each with the account's allocation, expected recovery and the no-substitute message:
   - **Tier A:** CRM-7A614127, CRM-6298B311, CRM-2AD8CC95.
   - **Tier B, no units:** Clearview CRM-1A44EA3D, Sunridge CRM-4FD13FB5.
   - **No contract, no units:** CRM-5B023F53, CRM-67453792, CRM-EB286193, CRM-F6C5E52D, CRM-DDF8277C, CRM-90F40CA5, CRM-695A0B57, CRM-4D0F1809, CRM-84AB5919, CRM-89E7E464, CRM-614AE560, CRM-C23D043D, CRM-73E758A1, CRM-21DD37FF, CRM-BE1BF35B, CRM-94A7168A, CRM-14C62855, CRM-B254B861.
4. **Case CASE-2F557A39 for Trade Relations:** to notify the two DC-EAST wholesalers, W-01 (Keystone) and W-02 (Atlas). The wholesaler messaging system has no connection I can use.

**Not done, and why**
- **No purchase requisition:** there is no qualified, approved alternate supplier for RM-221.
- **No allocation at DC-CENTRAL or DC-WEST:** they are above safety stock.
- **No stock transfer between DCs:** none was needed.
- **Wholesaler inventory not checked:** that data feed isn't live until Q4 2026.
- **Patient-level data not used** for allocation, as policy requires (POL-DUA-01).
- **RM-222 not acted on:** its PO isn't the next ship date. If it slips too, S-130 is a qualified alternate for it.
- **Recommendation only:** RM-221 has a single source, and so does the CMP-310 premix (S-201). Procurement should consider qualifying S-131 for RM-221.

**Assumptions**
- "Next ship date" means PO005791.
- A prescriber's state is the state of their clinic's account. Clinics roll up to their top-level account, up to three levels.
- The 13 weeks run from 2026-07-03 to 2026-09-25.
- "Contracted account" means every top-level account with prescriptions for these packs in DC-EAST's states, not only those with supply contracts.

Knowledge-layer sources: process Supply Disruption Response; rules BR-CUST-01, BR-REGION-01, BR-SUB-01/02, BR-LEAD-01, BR-ALLOC-01/02, BR-APPR-01 and POL-DUA-01; reference sets supply_contracts, list_prices, dc_service_regions and approved_substitutes; trace_supply_exposure and get_lead_times.

## Final state of the ops store (sandbox)

- **Allocation** AL-92E4600B · DC-EAST · NDC 99101010105 · approval APR-FBF71A6C: AC00038 15, AC00059 20, AC00117 11
- **Allocation** AL-A468D097 · DC-EAST · NDC 99101010110 · approval APR-FBF71A6C: AC00038 11, AC00059 15, AC00117 8
- **Approval** APR-FBF71A6C · allocation_plan · DC-EAST · $45,840 · approved by Supply Planning lead (oracle)
- **Case** CASE-2F557A39 → TRADE_RELATIONS: Notify DC-EAST wholesalers W-01 and W-02: Lacrivia supply delay (S-104 / RM-221)
- **CRM tasks** (23): AC00001, AC00017, AC00038, AC00059, AC00080, AC00101, AC00117, AC00138, AC00159, AC00160, AC00162, AC00164, AC00166, AC00167, AC00169, AC00171, AC00172, AC00174, AC00177, AC00178, AC00184, AC00185, AC00187
